Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review

被引:0
作者
D. C. B. Lye
A. Hughes
D. O'Brien
E. Athan
机构
[1] Level 7,Department of Infectious Diseases
[2] Geelong Hospital,undefined
来源
European Journal of Clinical Microbiology and Infectious Diseases | 2005年 / 24卷
关键词
Fluconazole; Caspofungin; Candida Glabrata; Prosthetic Valve Endocarditis; Oral Fluconazole;
D O I
暂无
中图分类号
学科分类号
摘要
Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery. Initial treatment with intravenous amphotericin B resulted in acute renal impairment. Despite 8 days of intravenous fluconazole therapy, he remained fungemic. Caspofungin was added to the treatment regimen with subsequent sterilisation of blood culture. The patient was treated for 34 days with caspofungin and 41 days with fluconazole. He continued oral fluconazole after hospital discharge and remained well at follow-up 11 months later. The role of fluconazole and caspofungin in the treatment of Candida endocarditis is discussed.
引用
收藏
页码:753 / 755
页数:2
相关论文
共 70 条
[1]  
Pappas PG(2004)Guidelines for treatment of candidiasis Clin Infect Dis 38 161-189
[2]  
Rex JH(2004)Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy Eur J Clin Microbiol Infect Dis 23 256-270
[3]  
Sobel JD(2001)Fungal endocarditis: evidence in the world literature, 1965–1995 Clin Infect Dis 32 50-62
[4]  
Groll AH(2002)Fungal endocarditis, 1995–2000 Chest 122 302-310
[5]  
Kolve H(1995)Surgical and long-term antifungal therapy for fungal prosthetic valve endocarditis Ann Thorac Surg 60 538-543
[6]  
Ellis ME(1997)Fungal prosthetic valve endocarditis in 16 patients: an 11-year experience in a tertiary care hospital Medicine (Baltimore) 76 94-103
[7]  
Al-Abdely H(1996) prosthetic valve endocarditis: prospective study of six cases and review of the literature Clin Infect Dis 22 262-267
[8]  
Sandridge A(2002)Antifungal susceptibility of Antimicrob Agents Chemother 46 1773-1780
[9]  
Greer W(2002) biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins Antimicrob Agents Chemother 46 3634-3636
[10]  
Ventura W(1974)In vitro pharmacodynamic properties of three antifungal agents against preformed Chest 66 376-377